top of page
Home
About Us
Team
Science
Pipelines
Ulcerative Colitis
Atopic Dermatitis
COVID-19
Diabetes
Nonalcoholic fatty liver disease
Gout
Investor Relations
Contact
More
Use tab to navigate through the menu items.
Investor Relations
SEC Filings
Investor Relations
NEWS / EVENTS
Press Release
Events & Presentations
SEC FILINGS
STOCK INFO
GOVERNANCE
Governance Documents
9/2/25
3
Initial statement of beneficial ownership of securities
html
9/2/25
3
Initial statement of beneficial ownership of securities
html
9/2/25
3
Initial statement of beneficial ownership of securities
html
9/2/25
3
Initial statement of beneficial ownership of securities
html
9/2/25
3
Initial statement of beneficial ownership of securities
html
9/2/25
3
Initial statement of beneficial ownership of securities
html
9/2/25
3
Initial statement of beneficial ownership of securities
html
9/2/25
3
Initial statement of beneficial ownership of securities
html
8/27/25
8-K
Current report
html
8/26/25
424B4
Prospectus filed pursuant to Rule 424(b)(4)
html
1
2
3
4
5
1
...
1
2
3
4
5
6
7
...
7
bottom of page